SCHEMBL29471259

SCHEMBL29471259

COc1cc(N2CCN(C)c3ccc(C#N)cc32)c2cc(C)c(=O)n(C)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRPF1 P55201 9/20 0.39
▸ BRD1 O95696 6/20 0.39
▸ BRPF3 Q9ULD4 6/20 0.39
▸ BRD4 O60885 4/20 0.39
▸ BRD9 Q9H8M2 4/20 0.39
▸ BRD7 Q9NPI1 2/20 0.38
▸ TRIM24 O15164 1/20 0.38
▸ USP14 P54578 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ KDM1A O60341 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ GPR6 P46095 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548588 1.00 BRPF1 (0.39) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL31542345 0.86 BRPF1 (0.35) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL24317223 0.86 RXFP1 (0.38) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL29471157 0.86 RXFP1 (0.38) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL31542279 0.86 BRPF1 (0.35) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL24316561 0.84 BRPF1 (0.40) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL31542282 0.83 BRPF1 (0.37) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL29471262 0.83 MAPT (0.37) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL26548555 0.83 MAPT (0.37) BRPF1BRD1BRPF3BRD4BRD9
SCHEMBL24317222 0.82 MAPT (0.35) BRPF1TP53EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025062330-A1 HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS AURIGENE ONCOLOGY LIMITED (IN) 2025-03-27 — — WO disclosed
EP-4210683-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS Aurigene Oncology Limited (IN) 2023-07-19 — — EP disclosed
CN-116368128-A Heterocyclic compounds as CBP/EP300 bromodomain inhibitors 奥瑞基尼肿瘤有限公司 2023-06-30 — — CN disclosed
WO-2022053967-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2022-03-17 — — WO disclosed
Send feedback